Regenxbio (RGNX) FCF Margin Growth (1y) (2015 - 2025)
Regenxbio (RGNX) FCF Margin Growth (1y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Regenxbio |
315.11 Mn |
85.04 Mn |
- |
-1,485.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-1,485.00 |
| Sep 30, 2025 |
-2,093.00 |
| Jun 30, 2025 |
-2,665.00 |
| Mar 31, 2025 |
39,518.00 |
| Dec 31, 2024 |
3,441.00 |
| Sep 30, 2024 |
693.00 |
| Jun 30, 2024 |
4,359.00 |
| Mar 31, 2024 |
8,944.00 |
| Dec 31, 2023 |
-4,551.00 |
| Sep 30, 2023 |
3,351.00 |
| Jun 30, 2023 |
-3,236.00 |
| Mar 31, 2023 |
-14,698.00 |
| Dec 31, 2022 |
-22,506.00 |
| Sep 30, 2022 |
-1,048.00 |
| Jun 30, 2022 |
3,633.00 |
| Mar 31, 2022 |
9,651.00 |
| Dec 31, 2021 |
2,303.00 |
| Sep 30, 2021 |
-16,997.00 |
| Jun 30, 2021 |
-10,420.00 |
| Mar 31, 2021 |
-16,967.00 |
